The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Total Current Liabilities: BDT0.00 Mil (As of . 20)


DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
20 GF Score
Price BDT319.40
View Full Analysis

What is The IBN SINA Pharmaceutical Industry Total Current Liabilities?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA +0.66% 20 Total Current Liabilities is BDT0.00 Mil as of . 20. GuruFocus rates DHA:IBNSINA with a GF Score™ of 20/100.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. The IBN SINA Pharmaceutical Industry's total current liabilities for the quarter that ended in . 20 was BDT0.00

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

The IBN SINA Pharmaceutical Industry Total Current Liabilities Related Terms

The IBN SINA Pharmaceutical Industry Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry Total Current Liabilities Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Total Current Liabilities

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Total Current Liabilities
DHA:IBNSINA
20GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

The IBN SINA Pharmaceutical Industry's Total Current Liabilities for the fiscal year that ended in . 20 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=+
+Other Current Liabilities+Current Deferred Liabilities
=+
=0.00

The IBN SINA Pharmaceutical Industry's Total Current Liabilities for the quarter that ended in . 20 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=+
+Other Current Liabilities+Current Deferred Liabilities
=+
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of BDT0.00 Mil mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a Total Current Liabilities of BDT0.00 Mil as of . 20. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for The IBN SINA Pharmaceutical Industry and its competitors.
Is The IBN SINA Pharmaceutical Industry's Total Current Liabilities too high?
The IBN SINA Pharmaceutical Industry's current Total Current Liabilities is BDT0.00 Mil. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's Total Current Liabilities compare to IMNPQ?
The IBN SINA Pharmaceutical Industry's Total Current Liabilities of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Drug Manufacturers company?
A good Total Current Liabilities depends on the Drug Manufacturers industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for The IBN SINA Pharmaceutical Industry and its competitors. The IBN SINA Pharmaceutical Industry's current Total Current Liabilities is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current Total Current Liabilities of BDT0.00 Mil. The current Total Current Liabilities is BDT0.00 Mil. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current Total Current Liabilities is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
20GF Score

Get the complete analysis for DHA:IBNSINA

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT319.40
Price